DILI: New Insights into Diagnosis and Management

Overview

Journal Curr Hepat Rep

Publisher Springer

Date 2013 Jun 5

PMID 23730228

Citations 5

Authors

Thanh Tran

William M Lee

Affiliations

Soon will be listed here.

Abstract

Drug-induced liver injury continues to have a significant impact. With over 1000 drugs now registered as causing DILI, this form of liver injury is the most cited reason for withdrawal of a drug from the marketplace. Despite this, the diagnosis of DILI continues to rely on subjective measures and expert opinion with results that are both difficult to verify and reproduce. However, recent developments in DILI research may provide new insights to improve diagnosis and treatment in the future.

Citing Articles

Effects of toxicants on endoplasmic reticulum stress and hepatic cell fate determination.

Tak J, Kim S Toxicol Res. 2023; 39(4):533-547.

PMID: 37779594 PMC: 10541383. DOI: 10.1007/s43188-023-00201-4.

Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice.

Zhai T, Zhang J, Zhang J, Liu B, Zhou Z, Liu F JHEP Rep. 2023; 5(4):100687.

PMID: 36923240 PMC: 10009536. DOI: 10.1016/j.jhepr.2023.100687.

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury.

Barbier-Torres L, Iruzubieta P, Fernandez-Ramos D, C Delgado T, Taibo D, Guitierrez-de-Juan V Nat Commun. 2017; 8(1):2068.

PMID: 29233977 PMC: 5727217. DOI: 10.1038/s41467-017-01970-x.

Systematic Review on Chinese Herbal Medicine Induced Liver Injury.

Zhang P, Ye Y, Yang X, Jiao Y Evid Based Complement Alternat Med. 2016; 2016:3560812.

PMID: 27651817 PMC: 5019919. DOI: 10.1155/2016/3560812.

MicroRNAs in Drug-induced Liver Injury.

Li L, Wang D, Zen K J Clin Transl Hepatol. 2015; 2(3):162-9.

PMID: 26357624 PMC: 4521241. DOI: 10.14218/JCTH.2014.00015.

References

Bond G . Acetaminophen protein adducts: a review. Clin Toxicol (Phila). 2008; 47(1):2-7. DOI: 10.1080/15563650801941831. View

Lee W . Drug-induced hepatotoxicity. N Engl J Med. 2003; 349(5):474-85. DOI: 10.1056/NEJMra021844. View

ODonohue J, Oien K, Donaldson P, Underhill J, Clare M, MacSween R . Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut. 2000; 47(5):717-20. PMC: 1728095. DOI: 10.1136/gut.47.5.717. View

Reuben A, Koch D, Lee W . Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010; 52(6):2065-76. PMC: 3992250. DOI: 10.1002/hep.23937. View

Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z . Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009; 106(11):4402-7. PMC: 2657429. DOI: 10.1073/pnas.0813371106. View

Benichou C, Danan G, Flahault A . Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993; 46(11):1331-6. DOI: 10.1016/0895-4356(93)90102-7. View

Larson A . Acetaminophen hepatotoxicity. Clin Liver Dis. 2007; 11(3):525-48, vi. DOI: 10.1016/j.cld.2007.06.006. View

Navarro V, Senior J . Drug-related hepatotoxicity. N Engl J Med. 2006; 354(7):731-9. DOI: 10.1056/NEJMra052270. View

Singer J, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L . A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet. 2010; 42(8):711-4. DOI: 10.1038/ng.632. View

10.

Bohan T, Helton E, McDonald I, Konig S, Gazitt S, Sugimoto T . Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology. 2001; 56(10):1405-9. DOI: 10.1212/wnl.56.10.1405. View

11.

Hautekeete M, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L . HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology. 1999; 117(5):1181-6. DOI: 10.1016/s0016-5085(99)70404-x. View

12.

Maria V, Victorino R . Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997; 26(3):664-9. DOI: 10.1002/hep.510260319. View

13.

Win S, Than T, Han D, Petrovic L, Kaplowitz N . c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 2011; 286(40):35071-8. PMC: 3186406. DOI: 10.1074/jbc.M111.276089. View

14.

Watkins P, Kaplowitz N, Slattery J, Colonese C, Colucci S, Stewart P . Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006; 296(1):87-93. DOI: 10.1001/jama.296.1.87. View

15.

Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-45. DOI: 10.1038/clpt.1981.154. View

16.

Mallal S, Phillips E, Carosi G, Molina J, Workman C, Tomazic J . HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008; 358(6):568-79. DOI: 10.1056/NEJMoa0706135. View

17.

Benichou C . Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990; 11(2):272-6. DOI: 10.1016/0168-8278(90)90124-a. View

18.

Larrey D . Drug-induced liver diseases. J Hepatol. 2000; 32(1 Suppl):77-88. DOI: 10.1016/s0168-8278(00)80417-1. View

19.

Robin M, Le Roy M, Descatoire V, Pessayre D . Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol. 1997; 26 Suppl 1:23-30. DOI: 10.1016/s0168-8278(97)82329-x. View

20.

James L, Letzig L, Simpson P, Capparelli E, Roberts D, Hinson J . Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 2009; 37(8):1779-84. PMC: 2712440. DOI: 10.1124/dmd.108.026195. View